The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study.

MLA

Gerosa, Maria, et al. “The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study.” Vaccines, vol. 10, no. 5, May 2022, p. 663. EBSCOhost, https://doi.org/10.3390/vaccines10050663.

APA

Gerosa, M., Schioppo, T., Argolini, L. M., Sciascia, S., Ramirez, G. A., Moroni, G., Sinico, R. A., Bonelli, G., Alberici, F., Mescia, F., Moroni, L., Tamborini, F., Miraglia, P., Bellocchi, C., Beretta, L., Roccatello, D., Dagna, L., Bozzolo, E., & Caporali, R. (2022). The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study. Vaccines, 10(5), 663. https://doi.org/10.3390/vaccines10050663

Chicago

Gerosa, Maria, Tommaso Schioppo, Lorenza Maria Argolini, Savino Sciascia, Giuseppe Alvise Ramirez, Gabriella Moroni, Renato Alberto Sinico, et al. 2022. “The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study.” Vaccines 10 (5): 663. doi:10.3390/vaccines10050663.